Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Taguchi

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Diabetes & Metabolism|April 28, 2023
Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED)Atsushi Tanaka, Yosuke Okada, Keiichi Torimoto, et al.
Eclinicalmedicine|September 27, 2023
Deep learning-based model detects atrial septal defects from electrocardiography: a cross-sectional multicenter hospital-based studyKotaro Miura, Ryuichiro Yagi, Hiroshi Miyama, et al.
Internal Medicine (Tokyo, Japan)|March 22, 2021
Gender Differences in the Circadian and Seasonal Variations in Patients with Takotsubo Syndrome: A Multicenter Registry at Eight University Hospitals in East JapanMichiko Yoshizawa, Tomonori Itoh, Yoshihiro Morino, et al.
Diabetes Care|September 20, 2019
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM TrialAtsushi Tanaka, Michio Shimabukuro, Noritaka Machii, et al.
BMC Medicine|November 14, 2022
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular eventsMasashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki, et al.
Cardiovascular Diabetology|April 6, 2016
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trialAtsushi Tanaka, Teruo Inoue, Masafumi Kitakaze, et al.
Heart and Vessels|April 3, 2020
A multicenter study on the clinical characteristics and risk factors of in-hospital mortality in patients with mechanical complications following acute myocardial infarctionYorihiko Koeda, Tomonori Itoh, Yu Ishikawa, et al.
Cardiovascular Diabetology|June 19, 2016
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE studyJun-Ichi Oyama, Atsushi Tanaka, Yasunori Sato, et al.
Plos Medicine|April 23, 2020
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trialAtsushi Tanaka, Isao Taguchi, Hiroki Teragawa, et al.
Cardiovascular Intervention and Therapeutics|October 10, 2020
Clinical and procedure characteristics in patients treated with polytetrafluoroethylene-covered stents after coronary perforation: a CIRC-8U multicenter registry and literature reviewTomonori Itoh, Takumi Kimura, Akihito Kudo, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Diabetes & Metabolism|April 28, 2023
Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED)Atsushi Tanaka, Yosuke Okada, Keiichi Torimoto, et al.
Eclinicalmedicine|September 27, 2023
Deep learning-based model detects atrial septal defects from electrocardiography: a cross-sectional multicenter hospital-based studyKotaro Miura, Ryuichiro Yagi, Hiroshi Miyama, et al.
Internal Medicine (Tokyo, Japan)|March 22, 2021
Gender Differences in the Circadian and Seasonal Variations in Patients with Takotsubo Syndrome: A Multicenter Registry at Eight University Hospitals in East JapanMichiko Yoshizawa, Tomonori Itoh, Yoshihiro Morino, et al.
Diabetes Care|September 20, 2019
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM TrialAtsushi Tanaka, Michio Shimabukuro, Noritaka Machii, et al.
BMC Medicine|November 14, 2022
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular eventsMasashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki, et al.
Cardiovascular Diabetology|April 6, 2016
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trialAtsushi Tanaka, Teruo Inoue, Masafumi Kitakaze, et al.
Heart and Vessels|April 3, 2020
A multicenter study on the clinical characteristics and risk factors of in-hospital mortality in patients with mechanical complications following acute myocardial infarctionYorihiko Koeda, Tomonori Itoh, Yu Ishikawa, et al.
Cardiovascular Diabetology|June 19, 2016
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE studyJun-Ichi Oyama, Atsushi Tanaka, Yasunori Sato, et al.
Plos Medicine|April 23, 2020
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trialAtsushi Tanaka, Isao Taguchi, Hiroki Teragawa, et al.
Cardiovascular Intervention and Therapeutics|October 10, 2020
Clinical and procedure characteristics in patients treated with polytetrafluoroethylene-covered stents after coronary perforation: a CIRC-8U multicenter registry and literature reviewTomonori Itoh, Takumi Kimura, Akihito Kudo, et al.
Pageof 16